Citation: J. Segreti et al., PROLONGED SUPPRESSIVE ANTIBIOTIC-THERAPY FOR INFECTED ORTHOPEDIC PROSTHESES, Clinical infectious diseases, 27(4), 1998, pp. 711-713
Authors:
FILE TM
SEGRETI J
DUNBAR L
PLAYER R
KOHLER R
WILLIAMS RR
KOJAK C
RUBIN A
Citation: Tm. File et al., A MULTICENTER, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF INTRAVENOUS AND OR ORAL LEVOFLOXACIN VERSUS CEFTRIAXONE AND/OR CEFUROXIME AXETIL IN TREATMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA/, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1965-1972
Authors:
SEGRETI J
GHEUSI G
DANTZER R
KELLEY KW
JOHNSON RW
Citation: J. Segreti et al., DEFECT IN INTERLEUKIN-1-BETA SECRETION PREVENTS SICKNESS BEHAVIOR IN C3H HEJ MICE/, Physiology & behavior, 61(6), 1997, pp. 873-878
Authors:
PULVIRENTI J
MEHRA T
DEMARAIS P
HAFIZ J
FISHER S
MARSH D
NATHAN C
KOCKA F
SEGRETI J
GOODMAN L
WEINSTEIN R
Citation: J. Pulvirenti et al., COMPARATIVE INCIDENCE OF CLOSTRIDIUM-DIFFICILE IN CONSECUTIVELY ADMITTED PATIENTS TO 2 SPECIALIZED HIV CARE UNITS IN 2 HOSPITALS, Clinical infectious diseases, 23(4), 1996, pp. 246-246
Citation: J. Segreti et al., IN-VITRO ACTIVITY OF MACROLIDES AGAINST INTRACELLULAR LEGIONELLA-PNEUMOPHILA, Diagnostic microbiology and infectious disease, 25(3), 1996, pp. 123-126
Citation: Lc. Ellis et al., JOINT INFECTIONS DUE TO LISTERIA-MONOCYTOGENES - CASE-REPORT AND REVIEW, Clinical infectious diseases, 20(6), 1995, pp. 1548-1550
Authors:
SEGRETI J
KRAATZ J
GOLDMAN M
TRENHOLME GM
Citation: J. Segreti et al., IN-VITRO ACTIVITY OF FK-037 - A PARENTERAL CEPHALOSPORIN, Diagnostic microbiology and infectious disease, 20(3), 1994, pp. 175-179
Authors:
JONES RN
KEHRBERG EN
ERWIN ME
ANDERSON SC
BEAVIS K
BERMAN M
BOURBEAU P
SINNOTT J
CANAWATI H
CAVALIERI S
COCKERILL F
DELLALATTA P
DENYS G
DOERN G
FORBES B
GAMBLE S
GOODMAN N
HAUGEN T
HINDLER J
HUMPHRIES J
JOSEPHSON S
KAUFFMAN C
LIBERTINE C
MAUNEY C
METCHOCK B
MICHELSON P
MURRAY P
NEEDHAM C
OELSCHDAEGER R
PRICE M
SACEANU C
SCHWALBE R
SEGRETI J
SEWELL D
SIERRA M
SLIFKIN M
SNYDMAN D
SOUTHERN P
SPIEGEL C
STEELEMOORE L
STEIN G
STRATTON C
WANGER A
WASHINGTON J
WASILAUSKAS B
WEINSTEIN M
Citation: Rn. Jones et al., PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 203-215
Citation: J. Segreti et Ks. Kapell, IN-VITRO ACTIVITY OF DIRITHROMYCIN AGAINST CHLAMYDIA-TRACHOMATIS, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2213-2214
Citation: J. Segreti et Gm. Trenholme, BETA-LACTAMASE INHIBITORS AND NEW CEPHALOSPORINS, Current opinion in infectious diseases, 6(6), 1993, pp. 731-736
Citation: J. Segreti et al., IN-VITRO ACTIVITY OF NEW QUINOXALINE COMPOUNDS AGAINST CAMPYLOBACTER SPECIES AND CLOSTRIDIUM-DIFFICILE, Diagnostic microbiology and infectious disease, 17(2), 1993, pp. 177-179
Authors:
TAN JS
WISHNOW RM
TALAN DA
DUNCANSON FP
NORDEN CW
HANNA C
CHRISTOU N
BERNSTEIN J
MARSH P
SMITH M
SAPICO F
MURRAY G
CROCKERSMITH LL
SEGRETI J
GENTRY L
CULLISON J
SATHE S
LOW I
LAMOTHE F
MERSEY J
DALL L
LAVERDIERE M
MITCHELL J
Citation: Js. Tan et al., TREATMENT OF HOSPITALIZED-PATIENTS WITH COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS - DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY OF PIPERACILLIN-TAZOBACTAM VERSUS TICARCILLIN-CLAVULANATE, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1580-1586
Authors:
LEVIN JM
NELSON JA
SEGRETI J
HARRISON B
BENSON CA
STRLE F
Citation: Jm. Levin et al., IN-VITRO SUSCEPTIBILITY OF BORRELIA-BURGDORFERI TO 11 ANTIMICROBIAL AGENTS, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1444-1446